All articles by RanjithKumar Dharma

RanjithKumar Dharma

FDA approves Abbott’s Epic Max stented tissue valve

Epic Max features a low-profile frame that enables potential future transcatheter interventions for patients.

FDA grants 510(k) clearance to CoreLink’s Siber Ti System

The Siber Ti System provides a comprehensive portfolio of fully porous, nano surfaced, 3D-printed implants.

Acutis Diagnostics selects Sophia Genetics’ technology for genomic assay

The new test is expected to help with genomic screening during patient recruitment for oncology clinical studies.

Health Canada authorises bioLytical’s syphilis antibody test

The test can identify both HIV-1/2 and syphilis antibodies from one simple fingerprick sample.

Illumina and GenoScreen introduce new tuberculosis test

The test can detect TB mycobacteria, as well as more than 100 non-TB mycobacterial species.

Askel to commercialise COPLA implant in US and EU by 2028

Designed to treat knee cartilage defects, the implant is being used for selected patients in a clinical trial.

Medtronic announces integration of NVIDIA’s AI tech with GI Genius platform

The GI Genius module is intended to help physicians identify polyps that can cause colorectal cancer.

Wesper receives FDA approval for next-generation sleep care device

The new device will gather significant clinical-grade longitudinal data to diagnose and monitor treatment efficacy over time.

Synchron to start patient enrolment in brain-computer interface study

The trial will evaluate the impact of the Synchron Switch on daily tasks, including texting, emailing and online shopping.

US FDA issues 510(k) approval to SurgVision’s Explorer Air II device

The Explorer Air II device will meet the requirements of oncological intraoperative fluorescence imaging.